Jazz Pharmaceuticals plc SEC filings JAZZ

Jazz Pharmaceuticals plc has 1,000 filings in SEC EDGAR's recent list, going back to Jun 20, 2017. Its latest annual report, Form ARS, was filed on Jun 8, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 2, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (results of operations). The company's fiscal year ends on December 31.

Jazz Pharmaceuticals plc SEC filings
Form Description Filed Period
4 Insider transaction Nov 4, 2026 Nov 2, 2026
144 Notice of proposed sale Nov 4, 2026 —
144 Notice of proposed sale Nov 3, 2026 —
144 Notice of proposed sale Nov 2, 2026 —
10-Q Quarterly report Nov 2, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 2, 2026 Nov 2, 2026
8-K Current report
Results of operations
Oct 26, 2026 Oct 26, 2026
8-K Current report
Officer or director change
Oct 9, 2026 Oct 6, 2026
144 Notice of proposed sale Oct 8, 2026 —
4 Insider transaction Oct 7, 2026 Oct 6, 2026
144 Notice of proposed sale Oct 6, 2026 —
4 Insider transaction Oct 5, 2026 Oct 1, 2026
144 Notice of proposed sale Oct 1, 2026 —
8-K Current report
Material agreement, New debt
Sep 23, 2026 Sep 23, 2026
8-K Current report
Regulation FD disclosure
Sep 15, 2026 Sep 15, 2026
4 Insider transaction Sep 14, 2026 Sep 10, 2026
4 Insider transaction Sep 10, 2026 Sep 8, 2026
4 Insider transaction Sep 10, 2026 Sep 8, 2026
144 Notice of proposed sale Sep 10, 2026 —
144 Notice of proposed sale Sep 8, 2026 —
144 Notice of proposed sale Sep 8, 2026 —
4 Insider transaction Sep 2, 2026 Aug 31, 2026
4 Insider transaction Sep 2, 2026 Aug 31, 2026
4 Insider transaction Sep 2, 2026 Aug 31, 2026
4 Insider transaction Sep 2, 2026 Aug 31, 2026
4 Insider transaction Sep 2, 2026 Aug 31, 2026
4 Insider transaction Sep 2, 2026 Aug 31, 2026
4 Insider transaction Sep 2, 2026 Aug 31, 2026
4 Insider transaction Sep 2, 2026 Aug 31, 2026
4 Insider transaction Sep 2, 2026 Aug 31, 2026
4 Insider transaction Sep 2, 2026 Aug 31, 2026
4 Insider transaction Sep 2, 2026 Aug 31, 2026
144 Notice of proposed sale Sep 1, 2026 —
4 Insider transaction Aug 31, 2026 Aug 27, 2026
8-K Current report
Material agreement, New debt, Unregistered share sale, Other events
Aug 31, 2026 Aug 26, 2026
144 Notice of proposed sale Aug 31, 2026 —
144 Notice of proposed sale Aug 31, 2026 —
144 Notice of proposed sale Aug 31, 2026 —
144 Notice of proposed sale Aug 31, 2026 —
144 Notice of proposed sale Aug 31, 2026 —
144 Notice of proposed sale Aug 31, 2026 —
144 Notice of proposed sale Aug 31, 2026 —
144 Notice of proposed sale Aug 31, 2026 —
144 Notice of proposed sale Aug 31, 2026 —
144 Notice of proposed sale Aug 31, 2026 —
144 Notice of proposed sale Aug 31, 2026 —
144 Notice of proposed sale Aug 27, 2026 —
8-K Current report
Other events
Aug 25, 2026 Aug 25, 2026
8-K Current report
Material agreement
Aug 10, 2026 Aug 10, 2026
8-K Current report
Regulation FD disclosure
Aug 10, 2026 Aug 10, 2026
4 Insider transaction Aug 7, 2026 Aug 5, 2026
4 Insider transaction Aug 7, 2026 Aug 5, 2026
4 Insider transaction Aug 7, 2026 Aug 5, 2026
4 Insider transaction Aug 7, 2026 Aug 5, 2026
4 Insider transaction Aug 7, 2026 Aug 5, 2026
4 Insider transaction Aug 7, 2026 Aug 5, 2026
4 Insider transaction Aug 7, 2026 Aug 5, 2026
4 Insider transaction Aug 7, 2026 Aug 5, 2026
4 Insider transaction Aug 7, 2026 Aug 5, 2026
4 Insider transaction Aug 7, 2026 Aug 5, 2026
4 Insider transaction Aug 7, 2026 Aug 5, 2026
4 Insider transaction Aug 7, 2026 Aug 5, 2026
144 Notice of proposed sale Aug 7, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Aug 6, 2026 —
4 Insider transaction Aug 5, 2026 Aug 3, 2026
144 Notice of proposed sale Aug 3, 2026 —
10-Q Quarterly report Aug 3, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 3, 2026 Aug 3, 2026
8-K Current report
Shareholder vote results
Jul 24, 2026 Jul 23, 2026
DEFA14A Additional proxy material Jul 14, 2026 —
4 Insider transaction Jul 6, 2026 Jul 1, 2026
4 Insider transaction Jul 2, 2026 Jun 30, 2026
4 Insider transaction Jul 2, 2026 Jun 30, 2026
4 Insider transaction Jul 2, 2026 Jun 30, 2026
4 Insider transaction Jul 2, 2026 Jun 30, 2026
4 Insider transaction Jul 2, 2026 Jun 30, 2026
144 Notice of proposed sale Jul 1, 2026 —
4 Insider transaction Jun 17, 2026 Jun 15, 2026
144 Notice of proposed sale Jun 15, 2026 —
4 Insider transaction Jun 12, 2026 Jun 10, 2026
144 Notice of proposed sale Jun 10, 2026 —
ARS Annual report to shareholders Jun 8, 2026 Dec 31, 2025
DEFA14A Additional proxy material Jun 8, 2026 —
DEF 14A Proxy statement Jun 8, 2026 Jul 23, 2026
4 Insider transaction Jun 5, 2026 Jun 3, 2026
4 Insider transaction Jun 3, 2026 Jun 1, 2026
144 Notice of proposed sale Jun 1, 2026 —
4 Insider transaction Jun 1, 2026 May 28, 2026
4 Insider transaction Jun 1, 2026 May 28, 2026
4 Insider transaction Jun 1, 2026 May 28, 2026
PRE 14A Preliminary proxy statement May 29, 2026 Jul 23, 2026
8-K Current report
Officer or director change
May 29, 2026 May 25, 2026
144 Notice of proposed sale May 28, 2026 —
144 Notice of proposed sale May 28, 2026 —
4 Insider transaction May 27, 2026 May 22, 2026
4 Insider transaction May 27, 2026 May 22, 2026
144 Notice of proposed sale May 22, 2026 —
144 Notice of proposed sale May 22, 2026 —
4 Insider transaction May 5, 2026 May 1, 2026
10-Q Quarterly report May 5, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 5, 2026 May 5, 2026
144 Notice of proposed sale May 1, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Apr 30, 2026 —
10-K/A Amended annual report Apr 24, 2026 Dec 31, 2025
4 Insider transaction Apr 3, 2026 Apr 1, 2026
144 Notice of proposed sale Apr 1, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 27, 2026 —
4 Insider transaction Mar 9, 2026 Mar 5, 2026
4 Insider transaction Mar 9, 2026 Mar 5, 2026
4 Insider transaction Mar 9, 2026 Mar 5, 2026
4 Insider transaction Mar 9, 2026 Mar 5, 2026
4 Insider transaction Mar 9, 2026 Mar 5, 2026
4 Insider transaction Mar 9, 2026 Mar 5, 2026
4 Insider transaction Mar 9, 2026 Mar 5, 2026
4 Insider transaction Mar 9, 2026 Mar 5, 2026
144 Notice of proposed sale Mar 9, 2026 —
144 Notice of proposed sale Mar 5, 2026 —
144 Notice of proposed sale Mar 5, 2026 —
4 Insider transaction Mar 4, 2026 Mar 3, 2026
144 Notice of proposed sale Mar 3, 2026 —
4 Insider transaction Mar 2, 2026 Feb 27, 2026
4 Insider transaction Mar 2, 2026 Feb 26, 2026
4 Insider transaction Mar 2, 2026 Feb 26, 2026
4 Insider transaction Mar 2, 2026 Feb 26, 2026
4 Insider transaction Mar 2, 2026 Feb 26, 2026
4 Insider transaction Mar 2, 2026 Feb 26, 2026
4 Insider transaction Mar 2, 2026 Feb 26, 2026
4 Insider transaction Mar 2, 2026 Feb 26, 2026
4 Insider transaction Mar 2, 2026 Feb 26, 2026
144 Notice of proposed sale Feb 27, 2026 —
144 Notice of proposed sale Feb 27, 2026 —
144 Notice of proposed sale Feb 26, 2026 —
144 Notice of proposed sale Feb 26, 2026 —
144 Notice of proposed sale Feb 26, 2026 —
10-K Annual report Feb 24, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 24, 2026 Feb 24, 2026
4 Insider transaction Jan 21, 2026 Jan 16, 2026
4 Insider transaction Jan 21, 2026 Jan 16, 2026
4 Insider transaction Jan 21, 2026 Jan 16, 2026
4 Insider transaction Jan 21, 2026 Jan 16, 2026
4 Insider transaction Jan 21, 2026 Jan 16, 2026
4 Insider transaction Jan 21, 2026 Jan 16, 2026
4 Insider transaction Jan 21, 2026 Jan 16, 2026
8-K Current report
Results of operations
Jan 12, 2026 Jan 12, 2026
4 Insider transaction Jan 8, 2026 Aug 18, 2025
4 Insider transaction Dec 11, 2025 Dec 9, 2025
3 Initial insider ownership Dec 10, 2025 Dec 1, 2025
144 Notice of proposed sale Dec 9, 2025 —
4 Insider transaction Dec 9, 2025 Dec 5, 2025
4 Insider transaction Dec 9, 2025 Dec 5, 2025
144 Notice of proposed sale Dec 5, 2025 —
4 Insider transaction Dec 4, 2025 Dec 2, 2025
144 Notice of proposed sale Dec 1, 2025 —
4 Insider transaction Dec 1, 2025 Nov 26, 2025
144 Notice of proposed sale Nov 26, 2025 —
4 Insider transaction Nov 24, 2025 Nov 20, 2025
4 Insider transaction Nov 21, 2025 Nov 19, 2025
4 Insider transaction Nov 20, 2025 Nov 18, 2025
4 Insider transaction Nov 20, 2025 Nov 18, 2025
4 Insider transaction Nov 20, 2025 Nov 18, 2025
144 Notice of proposed sale Nov 20, 2025 —
144 Notice of proposed sale Nov 19, 2025 —
4 Insider transaction Nov 19, 2025 Nov 17, 2025
144 Notice of proposed sale Nov 18, 2025 —
144 Notice of proposed sale Nov 18, 2025 —
144 Notice of proposed sale Nov 18, 2025 —
144 Notice of proposed sale Nov 17, 2025 —
8-K Current report
Other events
Nov 17, 2025 Nov 17, 2025
10-Q Quarterly report Nov 5, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 5, 2025 Nov 5, 2025
8-K Current report
Officer or director change
Oct 28, 2025 Oct 23, 2025
8-K Current report
Other events
Oct 22, 2025 Oct 21, 2025
4 Insider transaction Oct 3, 2025 Oct 1, 2025
144 Notice of proposed sale Oct 3, 2025 —
4 Insider transaction Sep 17, 2025 Sep 14, 2025
4 Insider transaction Sep 4, 2025 Sep 2, 2025
4 Insider transaction Aug 11, 2025 Aug 7, 2025
4 Insider transaction Aug 11, 2025 Aug 7, 2025
4 Insider transaction Aug 11, 2025 Aug 7, 2025
4 Insider transaction Aug 11, 2025 Aug 7, 2025
4 Insider transaction Aug 11, 2025 Aug 7, 2025
4 Insider transaction Aug 11, 2025 Aug 7, 2025
4 Insider transaction Aug 11, 2025 Aug 7, 2025
4 Insider transaction Aug 11, 2025 Aug 7, 2025
4 Insider transaction Aug 11, 2025 Aug 7, 2025
4 Insider transaction Aug 11, 2025 Aug 7, 2025
4 Insider transaction Aug 11, 2025 Aug 7, 2025
4 Insider transaction Aug 11, 2025 Aug 7, 2025
144 Notice of proposed sale Aug 8, 2025 —
144 Notice of proposed sale Aug 8, 2025 —
144 Notice of proposed sale Aug 8, 2025 —
144 Notice of proposed sale Aug 8, 2025 —
UPLOAD Letter from the SEC Aug 8, 2025 —
144 Notice of proposed sale Aug 8, 2025 —
144 Notice of proposed sale Aug 8, 2025 —
144 Notice of proposed sale Aug 8, 2025 —
144 Notice of proposed sale Aug 8, 2025 —
144 Notice of proposed sale Aug 8, 2025 —
144 Notice of proposed sale Aug 8, 2025 —
4 Insider transaction Aug 7, 2025 Aug 5, 2025

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
JAZZ (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Ireland
Headquarters
Dublin
SEC filer status
Large accelerated filer
SEC CIK
1232524
Former names
JAZZ PHARMACEUTICALS INC (until Jan 18, 2012)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.